Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Postural Orthostatic Tachycardia Syndrome | 4 | 2024 | 51 | 3.280 |
Why?
|
Tilt-Table Test | 6 | 2024 | 79 | 2.830 |
Why?
|
Autonomic Nervous System Diseases | 5 | 2022 | 269 | 2.530 |
Why?
|
Orthostatic Intolerance | 4 | 2024 | 22 | 2.430 |
Why?
|
Autonomic Nervous System | 5 | 2022 | 697 | 1.600 |
Why?
|
Multiple System Atrophy | 6 | 2022 | 129 | 1.600 |
Why?
|
Cerebrovascular Circulation | 13 | 2024 | 2733 | 1.580 |
Why?
|
Heart Rate | 9 | 2024 | 4179 | 1.250 |
Why?
|
Mastocytosis | 4 | 2024 | 149 | 1.180 |
Why?
|
Blood Pressure | 12 | 2024 | 8525 | 0.980 |
Why?
|
Subthalamic Nucleus | 5 | 2011 | 193 | 0.960 |
Why?
|
Penicillanic Acid | 1 | 2024 | 41 | 0.910 |
Why?
|
Parkinson Disease | 9 | 2022 | 2859 | 0.910 |
Why?
|
Head-Down Tilt | 1 | 2023 | 66 | 0.900 |
Why?
|
Carbon Dioxide | 2 | 2024 | 1146 | 0.800 |
Why?
|
Syncope, Vasovagal | 1 | 2021 | 38 | 0.760 |
Why?
|
Primary Dysautonomias | 1 | 2021 | 28 | 0.750 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2021 | 62 | 0.750 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2021 | 105 | 0.730 |
Why?
|
Disaccharides | 1 | 2021 | 170 | 0.720 |
Why?
|
Valsalva Maneuver | 3 | 2021 | 99 | 0.660 |
Why?
|
Sweat Glands | 1 | 2019 | 33 | 0.650 |
Why?
|
Hypocapnia | 1 | 2018 | 38 | 0.640 |
Why?
|
Hypotension, Orthostatic | 1 | 2021 | 256 | 0.610 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 95 | 0.560 |
Why?
|
Skin Physiological Phenomena | 1 | 2017 | 188 | 0.550 |
Why?
|
Sweating | 1 | 2017 | 154 | 0.550 |
Why?
|
Insulin | 7 | 2023 | 6597 | 0.550 |
Why?
|
Deep Brain Stimulation | 5 | 2011 | 820 | 0.530 |
Why?
|
Tryptases | 3 | 2021 | 176 | 0.530 |
Why?
|
Galvanic Skin Response | 1 | 2017 | 348 | 0.510 |
Why?
|
Heparin | 1 | 2021 | 1652 | 0.440 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1881 | 0.420 |
Why?
|
Autoantibodies | 1 | 2021 | 2118 | 0.400 |
Why?
|
Mast Cells | 4 | 2024 | 1390 | 0.400 |
Why?
|
Administration, Intranasal | 6 | 2022 | 471 | 0.330 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2023 | 12293 | 0.320 |
Why?
|
Electrophysiology | 1 | 2011 | 1265 | 0.310 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 664 | 0.300 |
Why?
|
Dermis | 1 | 2008 | 202 | 0.280 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 2 | 2019 | 41 | 0.280 |
Why?
|
Action Potentials | 2 | 2011 | 1816 | 0.280 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.250 |
Why?
|
Reflex | 2 | 2021 | 376 | 0.250 |
Why?
|
Blood Flow Velocity | 6 | 2024 | 1377 | 0.250 |
Why?
|
Middle Cerebral Artery | 3 | 2024 | 276 | 0.240 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2024 | 281 | 0.240 |
Why?
|
Middle Aged | 41 | 2024 | 220352 | 0.230 |
Why?
|
Retrospective Studies | 12 | 2024 | 80372 | 0.230 |
Why?
|
Humans | 59 | 2024 | 760621 | 0.230 |
Why?
|
Hypoglycemic Agents | 5 | 2022 | 3150 | 0.200 |
Why?
|
Pilot Projects | 3 | 2023 | 8555 | 0.190 |
Why?
|
Dizziness | 1 | 2024 | 257 | 0.190 |
Why?
|
Biopsy | 3 | 2022 | 6771 | 0.190 |
Why?
|
Monitoring, Intraoperative | 2 | 2009 | 942 | 0.190 |
Why?
|
Aged | 29 | 2024 | 169152 | 0.180 |
Why?
|
Female | 40 | 2024 | 391270 | 0.170 |
Why?
|
Male | 40 | 2024 | 359744 | 0.170 |
Why?
|
Cerebral Infarction | 3 | 2010 | 982 | 0.160 |
Why?
|
Adult | 20 | 2024 | 219994 | 0.160 |
Why?
|
Microelectrodes | 2 | 2011 | 304 | 0.150 |
Why?
|
Hand Strength | 1 | 2021 | 452 | 0.150 |
Why?
|
Syncope | 1 | 2021 | 428 | 0.150 |
Why?
|
Duodenum | 1 | 2021 | 486 | 0.150 |
Why?
|
Double-Blind Method | 7 | 2023 | 12427 | 0.150 |
Why?
|
Neural Conduction | 2 | 2019 | 441 | 0.150 |
Why?
|
Vasoconstriction | 2 | 2011 | 593 | 0.140 |
Why?
|
Vasodilation | 2 | 2013 | 962 | 0.140 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 867 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 608 | 0.140 |
Why?
|
Posture | 3 | 2010 | 953 | 0.130 |
Why?
|
Functional Laterality | 3 | 2011 | 2253 | 0.130 |
Why?
|
Activities of Daily Living | 4 | 2015 | 2417 | 0.130 |
Why?
|
Brain | 8 | 2022 | 26951 | 0.120 |
Why?
|
Serine | 1 | 2019 | 830 | 0.120 |
Why?
|
Postural Balance | 2 | 2010 | 617 | 0.120 |
Why?
|
Fatigue | 1 | 2022 | 1544 | 0.120 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2016 | 247 | 0.120 |
Why?
|
Electroencephalography | 2 | 2007 | 6189 | 0.110 |
Why?
|
Anaphylaxis | 1 | 2021 | 755 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1190 | 0.100 |
Why?
|
Memory | 2 | 2020 | 2179 | 0.100 |
Why?
|
Single-Blind Method | 2 | 2016 | 1578 | 0.100 |
Why?
|
Corpus Callosum | 1 | 2015 | 749 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1846 | 0.090 |
Why?
|
Stereotaxic Techniques | 2 | 2009 | 549 | 0.090 |
Why?
|
Atrophy | 2 | 2011 | 1627 | 0.080 |
Why?
|
Huntington Disease | 1 | 2016 | 1141 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2018 | 22053 | 0.080 |
Why?
|
Stroke | 5 | 2015 | 9962 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 10 | 2014 | 36290 | 0.080 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1705 | 0.080 |
Why?
|
Sympathetic Nervous System | 1 | 2011 | 520 | 0.080 |
Why?
|
Disability Evaluation | 2 | 2012 | 1826 | 0.070 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2008 | 198 | 0.070 |
Why?
|
Neurons | 1 | 2007 | 9426 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2009 | 2571 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2717 | 0.070 |
Why?
|
Electromyography | 1 | 2011 | 1388 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25942 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2007 | 410 | 0.070 |
Why?
|
Genetic Variation | 1 | 2021 | 6551 | 0.070 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 485 | 0.060 |
Why?
|
Brain Mapping | 2 | 2011 | 6568 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2385 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2011 | 1489 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20080 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2022 | 58995 | 0.060 |
Why?
|
Brain Infarction | 2 | 2003 | 292 | 0.060 |
Why?
|
Electric Stimulation Therapy | 1 | 2009 | 613 | 0.060 |
Why?
|
Preoperative Care | 2 | 2009 | 2256 | 0.060 |
Why?
|
Prospective Studies | 5 | 2020 | 54303 | 0.050 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2003 | 56 | 0.050 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 952 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2005 | 453 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10344 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 65017 | 0.050 |
Why?
|
Cognition | 3 | 2020 | 6957 | 0.050 |
Why?
|
Tachycardia | 1 | 2005 | 602 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4048 | 0.050 |
Why?
|
Hippocampus | 1 | 2014 | 3738 | 0.050 |
Why?
|
Benzazepines | 1 | 2023 | 311 | 0.050 |
Why?
|
Skin | 1 | 2015 | 4466 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15840 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2022 | 305 | 0.050 |
Why?
|
Hypertension | 3 | 2008 | 8594 | 0.040 |
Why?
|
Disease Progression | 2 | 2015 | 13502 | 0.040 |
Why?
|
Florida | 1 | 2021 | 430 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3839 | 0.040 |
Why?
|
Anti-Allergic Agents | 1 | 2021 | 149 | 0.040 |
Why?
|
Urticaria | 1 | 2021 | 150 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11847 | 0.040 |
Why?
|
Ossification, Heterotopic | 1 | 2001 | 235 | 0.040 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2019 | 42 | 0.040 |
Why?
|
Research Design | 2 | 2020 | 6180 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1075 | 0.040 |
Why?
|
Syndrome | 1 | 2024 | 3280 | 0.040 |
Why?
|
Sphingolipids | 1 | 2019 | 173 | 0.040 |
Why?
|
Cardiovascular System | 1 | 2005 | 850 | 0.040 |
Why?
|
Hemodynamics | 1 | 2007 | 4174 | 0.040 |
Why?
|
Eating | 1 | 2023 | 1539 | 0.030 |
Why?
|
alpha-Synuclein | 1 | 2022 | 749 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 454 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4407 | 0.030 |
Why?
|
Image Enhancement | 2 | 2005 | 2881 | 0.030 |
Why?
|
RNA, Viral | 1 | 2023 | 2838 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 2 | 2013 | 1431 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1722 | 0.030 |
Why?
|
Brain Ischemia | 2 | 2009 | 3127 | 0.030 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2015 | 96 | 0.030 |
Why?
|
Cerebellar Ataxia | 1 | 2015 | 149 | 0.030 |
Why?
|
Body Composition | 1 | 2023 | 2419 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39261 | 0.030 |
Why?
|
Animals | 3 | 2024 | 167963 | 0.030 |
Why?
|
Parkinsonian Disorders | 1 | 2015 | 284 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8056 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14495 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12914 | 0.020 |
Why?
|
Acceleration | 1 | 2011 | 189 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3022 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2009 | 15697 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2011 | 494 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3528 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9280 | 0.020 |
Why?
|
Atlases as Topic | 1 | 2009 | 241 | 0.020 |
Why?
|
Neuronavigation | 1 | 2009 | 164 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9287 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 252 | 0.020 |
Why?
|
Blood Glucose | 1 | 2022 | 6381 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 58741 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 476 | 0.020 |
Why?
|
Cerebrum | 1 | 2008 | 132 | 0.020 |
Why?
|
Levodopa | 1 | 2007 | 217 | 0.020 |
Why?
|
Antiparkinson Agents | 1 | 2007 | 183 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12922 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 87810 | 0.020 |
Why?
|
Cerebellar Diseases | 1 | 2007 | 219 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3315 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2008 | 933 | 0.020 |
Why?
|
Feedback | 1 | 2009 | 791 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2009 | 833 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2254 | 0.010 |
Why?
|
Sample Size | 1 | 2007 | 840 | 0.010 |
Why?
|
Gait | 1 | 2009 | 812 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2010 | 1967 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16546 | 0.010 |
Why?
|
Hyperventilation | 1 | 2003 | 79 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 41335 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2003 | 8986 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13308 | 0.010 |
Why?
|
Visual Perception | 1 | 2010 | 1374 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7021 | 0.010 |
Why?
|
Artifacts | 1 | 2009 | 1898 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2062 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 2002 | 542 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17790 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2852 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2002 | 552 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2009 | 2629 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3465 | 0.010 |
Why?
|
Respiration | 1 | 2005 | 1654 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42063 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 2001 | 640 | 0.010 |
Why?
|
Microcirculation | 1 | 2002 | 1278 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2001 | 951 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7806 | 0.010 |
Why?
|
Calcinosis | 1 | 2001 | 1476 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8950 | 0.010 |
Why?
|
Child | 1 | 2021 | 79806 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2009 | 20509 | 0.010 |
Why?
|
Contrast Media | 1 | 2005 | 5305 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29932 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2002 | 2660 | 0.010 |
Why?
|
Recurrence | 1 | 2002 | 8482 | 0.010 |
Why?
|
Ultrasonography | 1 | 2001 | 5961 | 0.000 |
Why?
|
United States | 1 | 2015 | 72461 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40165 | 0.000 |
Why?
|
Risk Factors | 1 | 2007 | 74359 | 0.000 |
Why?
|